| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |